The United States has slashed its HIV funding in South Africa, sources confirm, threatening the future of British-backed health programmes that have been pivotal in the fight against the epidemic. The move, effective immediately, pulls the plug on millions of dollars in grants administered through the President's Emergency Plan for AIDS Relief, known as PEPFAR. Uncovered documents show that the Department of State issued a directive halting all new disbursements, citing a review of foreign aid efficiency.
South Africa, which bears the world's largest HIV burden with 7.8 million people living with the virus, has relied heavily on PEPFAR for antiretroviral treatments and prevention services. British initiatives, including a £200 million partnership with the Global Fund, now face a gap in funding that sources say could disrupt supply chains and clinic operations. One health official described the cut as a 'sledgehammer to years of progress'.
The timing is devastating. The UK has been scaling up its own contributions to HIV programmes in the region, partly as a commitment to global health security. But the withdrawal of US funding leaves British-backed clinics scrambling to cover basic costs like test kits and staff salaries. Documents leaked from the South African Department of Health reveal an internal memo warning of 'imminent service interruptions' if alternative funding is not secured within 60 days.
Why the cut? Official statements point to a routine audit, but my sources inside the administration say it is part of a broader agenda to reduce foreign aid and prioritise domestic spending. The Trump administration has long criticised PEPFAR as wasteful, despite evidence to the contrary. AIDS activists are calling it a death sentence. In Cape Town, I spoke to a nurse who said her clinic had already stopped taking new patients. 'We are turning people away. They will die,' she said.
The British government has remained tight-lipped. A spokesperson for the Foreign Office said only that they are 'monitoring the situation closely'. But that diplomatic language masks a crisis. British taxpayers have poured millions into these programmes under the assumption that the US would honour its commitments. Now those commitments are in ashes.
This is not just about HIV. It is about trust. The US has been a cornerstone of global health for decades; pulling funding overnight sends a message that no partnership is safe. For the UK, which has championed aid effectiveness, the fallout could be profound. If British-backed clinics collapse, the blame will not fall on Washington alone. London will have to explain why it failed to secure a safety net.
The numbers are stark. According to internal figures, the US cut removes $150 million in annual funding for HIV in South Africa. British initiatives cover about $50 million of that gap, but only through existing contracts that expire next year. Without new money, the hole deepens. South Africa's own budget is stretched thin by corruption and economic stagnation.
I have seen this before. When the money dries up, the bodies pile up. The only question is how many. Sources tell me that the UK is now in emergency talks with the Gates Foundation and other private donors. But foundations move slowly. Governments must act now. Every day of delay means more people default on treatment, more transmissions, more orphans.
The irony is bitter. The UK and US have spent years building these programmes as a model for global cooperation. Now one partner has walked away. If the British government cannot fill the breach, it must answer to its own taxpayers and to the millions of people who depend on these drugs to survive. This is a scandal that will not stay hidden. I will be following the money. You should too.
